Found 23 with Last Name = 'stocker' and Initial = 'jw' TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 360nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 550nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.75E+3nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 3.15E+3nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 4.30E+3nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
TargetIntermediate conductance calcium-activated potassium channel protein 4(Homo sapiens (Human))
Icagen, Inc.
Curated by ChEMBL
Icagen, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of Gardos channel in human RBC assessed as inhibition of ionomycin-stimulated [86Rb] effluxMore data for this Ligand-Target Pair
